C4 Therapeutics, Inc. (CCCC) vs ClearPoint Neuro, Inc. (CLPT)
A side-by-side comparison of C4 Therapeutics, Inc. and ClearPoint Neuro, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CCCC
C4 Therapeutics, Inc.
$2.97HealthcareDelayed quote: Oct 6, 2026, 10:05 AM EDT
CLPT
ClearPoint Neuro, Inc.
$11.39HealthcareDelayed quote: Oct 6, 2026, 10:05 AM EDT
Total return — CCCC vs CLPT
growth of $100 · dividends reinvested · last 6yCCCC -88.3% (-30.0%/yr)CLPT +125.5% (+14.5%/yr)CLPT compounded faster over this window
Log scale — wide-divergence pair
CCCC CLPT
CCCC vs CLPT: by the numbers
- •CLPT is the larger company ($341M vs $328M market cap).
- •Both run net losses; CLPT's is the smaller (-81.76% vs -289.44% net margin).
- •CLPT grew revenue faster over the past five years (23.57% vs 0.65% CAGR).
Metrics side by side
Valuation
| Metric | CCCC | CLPT |
|---|---|---|
| P/S ratio | 9.37 | 8.08 |
| P/B ratio | 1.33 | 31.69 |
Profitability
| Metric | CCCC | CLPT |
|---|---|---|
| Gross margin | 77.81% | 62.61% |
| Operating margin | -290.68% | -65.36% |
| Net margin | -289.44% | -81.76% |
| ROE | -41.02% | -320.77% |
| ROIC | -35.92% | -40.51% |
Growth (annualized)
| Metric | CCCC | CLPT |
|---|---|---|
| Revenue CAGR (5Y) | 0.65% | 23.57% |
| Total return CAGR (5Y) | -41.77% | -7.65% |
Frequently asked
- Which has grown faster, CCCC or CLPT?
- Over the past five years, CLPT grew revenue faster — CCCC at a 0.65% CAGR versus CLPT at 23.57%.
- How have CCCC and CLPT total returns compared?
- Over the past 5 years, CCCC delivered -41.77% and CLPT delivered -7.65% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
C4 Therapeutics ROEClearPoint Neuro ROEC4 Therapeutics operating marginClearPoint Neuro operating marginC4 Therapeutics revenue growthClearPoint Neuro revenue growthC4 Therapeutics free cash flowClearPoint Neuro free cash flow
C4 Therapeutics & ClearPoint Neuro appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.